Home | Health | More than 10,000 defibrillators in public places 'could be faulty'

More than 10,000 defibrillators in public places 'could be faulty'

More than 10,000 defibrillators in the UK may be affected by a fault, which means they will not work in an emergency.

The fault affects LIFEPAK 1000 devices, the Medicines and Healthcare products Regulatory Agency (MHRA) said.

The manufacturer, Physio-Control, has sent a safety alert to those with the devices concerned, urging them to check the battery connection.

The defibrillators are intended for use by anyone in public places.

They are found in schools, airports, leisure centres, hospitals, clinics and ambulances.

Physio-Control said it had received 34 reports of incidents where customers had attempted to use the defibrillator and it had shut down unexpectedly during treatment.

The MHRA said the fault was caused by an intermittent connection between the battery and device contacts because of wear and corrosion.

This could fail to deliver an electric shock to resuscitate a patient, it said.

There are 10,068 LIFEPAK 1000 devices in the UK.

The MHRA said any users who had yet to receive the safety alert should contact Physio-Control directly.

Guidelines for recommended use say LIFEPAK 1000 batteries should be removed and reinstalled every week.

What is a defibrillator?

  • It’s a device that gives a high energy electric shock to the heart through the chest wall to someone in cardiac arrest
  • This high energy shock is called defibrillation, and it’s an essential step in saving a life
  • If someone has had a cardiac arrest, call 999 and start chest compressions or CPR
  • Then find out if there is a defibrillator nearby

John Wilkinson, MHRA director of medical devices, said: “These devices deliver life-saving treatment and it is vital they operate correctly when needed in an emergency.

“People who are responsible for them should carry out the checks recommended by the manufacturer.

“If you have any questions, please contact Physio-Control on 0808 258 0094.”

In October, the same company issued a safety warning over two other defibrillator models.

Click here to Read from the source

antalya oto kiralama Google
x

Check Also

Puma Biotech shares soar on optimism over cancer drug approval

0SHARESShare Puma Biotechnology’s experimental breast cancer drug appears to be effective, though there is some ...

Shares
sunexpress